1. Home
  2. REI vs FBIOP Comparison

REI vs FBIOP Comparison

Compare REI & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REI
  • FBIOP
  • Stock Information
  • Founded
  • REI 2004
  • FBIOP N/A
  • Country
  • REI United States
  • FBIOP United States
  • Employees
  • REI N/A
  • FBIOP 186
  • Industry
  • REI Oil & Gas Production
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • Sector
  • REI Energy
  • FBIOP Health Care
  • Exchange
  • REI Nasdaq
  • FBIOP Nasdaq
  • Market Cap
  • REI N/A
  • FBIOP N/A
  • IPO Year
  • REI N/A
  • FBIOP N/A
  • Fundamental
  • Price
  • REI $1.53
  • FBIOP $5.10
  • Analyst Decision
  • REI
  • FBIOP
  • Analyst Count
  • REI 0
  • FBIOP 0
  • Target Price
  • REI N/A
  • FBIOP N/A
  • AVG Volume (30 Days)
  • REI 2.0M
  • FBIOP N/A
  • Earning Date
  • REI 11-06-2024
  • FBIOP N/A
  • Dividend Yield
  • REI N/A
  • FBIOP N/A
  • EPS Growth
  • REI 52.41
  • FBIOP N/A
  • EPS
  • REI 0.57
  • FBIOP N/A
  • Revenue
  • REI $365,608,400.00
  • FBIOP N/A
  • Revenue This Year
  • REI $11.08
  • FBIOP N/A
  • Revenue Next Year
  • REI $0.12
  • FBIOP N/A
  • P/E Ratio
  • REI $2.70
  • FBIOP N/A
  • Revenue Growth
  • REI 6.76
  • FBIOP N/A
  • 52 Week Low
  • REI $1.25
  • FBIOP N/A
  • 52 Week High
  • REI $2.20
  • FBIOP N/A
  • Technical
  • Relative Strength Index (RSI)
  • REI 47.01
  • FBIOP 38.27
  • Support Level
  • REI $1.44
  • FBIOP $5.00
  • Resistance Level
  • REI $1.77
  • FBIOP $5.50
  • Average True Range (ATR)
  • REI 0.08
  • FBIOP 0.46
  • MACD
  • REI 0.01
  • FBIOP -0.05
  • Stochastic Oscillator
  • REI 27.27
  • FBIOP 6.84

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Share on Social Networks: